Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201067 · ClinicalTrials.gov registry record
Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 240
- Enrollment target
NCT04201067: Completed study, sponsored by Mayo Clinic.
NCT04201067 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201067 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
Researchers are trying to determine the efficacy of a global metabolomic approach in testing for and diagnosing inborn errors of metabolism as opposed to traditional testing methods.
Primary Outcome
Measure N-linked glycan intermediates in plasma and urine from PMM2-CDG patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2025-03-12 |
What the finished NCT04201067 record still lists
NCT04201067 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04201067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04201067 about?
NCT04201067 is a clinical study titled "Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism". Researchers are trying to determine the efficacy of a global metabolomic approach in testing for and diagnosing inborn errors of metabolism as opposed to traditional testing methods.
What is the current status of trial NCT04201067?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2019-10-08. Estimated completion is 2025-03-12.
Who is sponsoring clinical trial NCT04201067?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI